These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19074075)

  • 1. The anemia of inflammation/malignancy: mechanisms and management.
    Adamson JW
    Hematology Am Soc Hematol Educ Program; 2008; ():159-65. PubMed ID: 19074075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anemia of inflammation.
    Stein BL
    J Clin Rheumatol; 2012 Dec; 18(8):437-42. PubMed ID: 23211586
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron sequestration and anemia of inflammation.
    Ganz T; Nemeth E
    Semin Hematol; 2009 Oct; 46(4):387-93. PubMed ID: 19786207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia of inflammation: the cytokine-hepcidin link.
    Andrews NC
    J Clin Invest; 2004 May; 113(9):1251-3. PubMed ID: 15124013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal anemia of inflammation: the name is self-explanatory.
    Yilmaz MI; Solak Y; Covic A; Goldsmith D; Kanbay M
    Blood Purif; 2011; 32(3):220-5. PubMed ID: 21829013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.
    Morceau F; Dicato M; Diederich M
    Mediators Inflamm; 2009; 2009():405016. PubMed ID: 20204172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
    Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
    Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations.
    Dallalio G; Law E; Means RT
    Blood; 2006 Apr; 107(7):2702-4. PubMed ID: 16332970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking anemia to inflammation and cancer: the crucial role of TNFalpha.
    Buck I; Morceau F; Grigorakaki C; Dicato M; Diederich M
    Biochem Pharmacol; 2009 May; 77(10):1572-9. PubMed ID: 19174153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
    Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
    Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia.
    Lasocki S; Millot S; Andrieu V; Lettéron P; Pilard N; Muzeau F; Thibaudeau O; Montravers P; Beaumont C
    Crit Care Med; 2008 Aug; 36(8):2388-94. PubMed ID: 18664788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyporesponsiveness to erythropoietin therapy in hemodialyzed patients: potential role of prohepcidin, hepcidin, and inflammation.
    Malyszko J; Malyszko JS; Mysliwiec M
    Ren Fail; 2009; 31(7):544-8. PubMed ID: 19839848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.
    Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T
    J Clin Invest; 2004 May; 113(9):1271-6. PubMed ID: 15124018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron metabolism in athletes--achieving a gold standard.
    Latunde-Dada GO
    Eur J Haematol; 2013 Jan; 90(1):10-5. PubMed ID: 23078160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
    Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in hepcidin and reticulocyte hemoglobin equivalent levels in response to continuous erythropoietin receptor activator administration in hemodialysis patients: a randomized study.
    Kakimoto-Shino M; Toya Y; Kuji T; Fujikawa T; Umemura S
    Ther Apher Dial; 2014 Oct; 18(5):421-6. PubMed ID: 24456328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of anemia of chronic disease].
    Matsumura I; Kanakura Y
    Nihon Rinsho; 2008 Mar; 66(3):535-9. PubMed ID: 18326322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin and cytokines in anaemia.
    Means RT
    Hematology; 2004; 9(5-6):357-62. PubMed ID: 15763974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepcidin and disorders of iron metabolism.
    Ganz T; Nemeth E
    Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepcidin during anemia requires erythropoietic activity.
    Pak M; Lopez MA; Gabayan V; Ganz T; Rivera S
    Blood; 2006 Dec; 108(12):3730-5. PubMed ID: 16882706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.